Clearmind Medicine CMND Income Statement (2022-2026)

NASDAQ CMND
$1.06 +0.03 (+2.91%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Clearmind Medicine Quarterly Income Statement

Periods 17 quarters
Latest Apr 2026

Clearmind Medicine reported net income of $2.05M for the quarter ended Apr 2026. This income statement covers 17 quarters of results from Jan 2022 through Apr 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jan2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Operating items
Research & DevelopmentR&D 0.34M0.33M1.28M0.59M0.23M0.26M0.38M0.01M0.32M0.35M0.49M0.46M0.45M0.72M0.42M0.64M0.65M
Selling, General & AdministrativeSG&A 1.31M1.03M-0.13M1.25M0.99M0.84M1.34M1.16M0.98M1.13M1.10M1.03M0.86M0.68M1.04M3.02M0.92M
Other Operating ExpensesOther Opex -0.00M0.21M-0.02M
Operating ExpensesOpex 1.65M1.35M1.15M1.83M1.22M1.10M1.71M1.38M1.30M1.47M1.59M1.50M1.31M1.41M1.46M3.66M1.57M
Operating IncomeOp. Inc -1.65M-1.83M-1.22M
EBIT -1.65M-1.48M-1.54M-1.83M-1.22M-0.06M-6.41M-1.17M-0.44M-2.07M0.10M-0.57M-0.76M-1.20M0.08M-4.04M-2.04M
Non-operating items
Non Operating Interest Expenses -0.01M-0.00M-0.30M0.52M-2.35M0.43M-0.02M0.88M0.46M0.10M0.77M-0.19M
Non Operating Investment IncomeNon-Op. Investment Inc. -0.06M-0.05M-0.01M-0.04M556.00-0.01M-0.06M-0.07M-0.16M-0.06M1.14M-0.57M0.44M
Interest & Investment IncomeInt & Inv Inc 0.03M0.22M0.43M0.46M0.54M-0.47M
Other Non Operating IncomeOther Non Op Inc. -0.01M-0.13M0.22M0.02M0.01M0.02M-0.05M-0.00M0.03M-0.06M-0.01M-0.01M-0.01M-0.01M0.01M-0.00M-0.00M
Non Operating IncomeNon Op. Inc. 0.02M-0.00M
Net income details
EBT -1.65M-1.48M-1.54M-1.90M-1.53M-0.58M-4.06M-1.17M-0.87M-2.05M-0.79M-1.03M-0.76M-1.31M-0.69M-3.85M-2.04M
Tax ProvisionsTaxes -0.00M-0.01M0.01M-0.01M-0.20M-0.04M-0.04M-0.10M-0.04M-0.02M-0.01M-0.00M-0.00M-0.00M
Profit After TaxPAT -1.65M-1.48M-1.57M1.90M2.08M0.58M4.07M1.37M0.91M2.09M0.88M1.07M0.78M1.31M0.69M3.85M2.05M
Income from Continuing OperationsIncome (Continuing) -1.65M-1.48M-1.54M-1.82M-1.52M-0.59M-4.05M-0.96M-0.83M-2.01M-0.69M-0.99M-0.74M-1.30M-0.68M-3.85M-2.04M
Consolidated Net IncomeConsol Net Inc. -1.65M-1.48M-1.54M-1.82M-1.52M-0.59M-4.05M-0.96M-0.83M-2.01M-0.69M-0.99M-0.74M-1.30M-0.68M-3.85M-2.04M
Income towards Parent CompanyParent Net Inc -1.65M-1.48M-1.54M-1.82M-1.52M-0.59M-4.05M-0.96M-0.83M-2.01M-0.69M-0.99M-0.74M-1.30M-0.68M-3.85M-2.04M
Net Income towards Common StockholdersNet Income -1.65M-1.48M-1.54M-1.82M-1.52M-0.59M-4.05M-0.96M-0.83M-2.01M-0.69M-0.99M-0.74M-1.30M-0.68M-3.85M-2.04M
Additional items
EPS (Basic) -89.10-128.12-95.82-167.36-53.78-302.67-160.60
EPS (Diluted) -89.10-128.12-95.82-167.36-53.78-302.67-160.60
Shares Outstanding 0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 0.01M0.01M
EBITDA -1.65M-1.48M-1.54M-1.83M-1.22M-0.06M-6.41M-1.17M-0.44M-2.07M0.10M-0.57M-0.76M-1.20M0.08M-4.04M-2.04M
Interest ExpensesInt Expense -0.01M-0.00M-0.30M0.52M-2.35M0.43M-0.02M0.88M0.46M0.10M0.77M-0.19M
Tax Rate 0.18%0.45%-1.14%0.28%17.28%4.22%2.08%12.33%3.81%2.71%0.63%0.32%0.10%0.16%